phase readout
saveNCT06332092: FID-007 and Cetuximab in Treating Patients With Advanced Head and Neck Squamous Cell Carcinoma
ACTIVE_NOT_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Fulgent Pharma LLC.. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma
view source ↗
comments(0)
5-min edit window · permanent after that